Overview of India's Universal Immunisation Program
Uploaded by
mrunalini chaudhariOverview of India's Universal Immunisation Program
Uploaded by
mrunalini chaudhariCommon questions
Powered by AICold chain management is crucial in India's UIP to ensure that vaccines are stored and transported at the correct temperatures to maintain their potency and effectiveness. Effective cold chain management prevents vaccine spoilage, ensuring that high-quality vaccines reach even remote areas. It is maintained through a series of refrigerated storage facilities and transport mechanisms, including walk-in coolers and freezers, which are systematically monitored for temperature fluctuations. Proper management also involves training health workers and leveraging technology to keep track of cold chain logistics .
To ensure vaccine safety and monitoring in India’s UIP, several measures are in place including the Adverse Events After Immunization (AEFI) surveillance system, which monitors and investigates vaccine-related adverse events to improve response strategies and build public confidence in vaccines. In addition, the Vaccine Logistics Management System (VLMS) helps track the storage and movement of vaccine supplies, ensuring they remain within safe temperature ranges to prevent spoilage .
Mission Indradhanush plays a pivotal role in addressing gaps in India's vaccination coverage by specifically targeting children and pregnant women who missed regular vaccinations. Launched in 2014, it aims to accelerate and expand immunization reach, particularly in geographical areas with low vaccination rates. The program strategically conducts high-intensity vaccination campaigns that are comprehensive and data-driven, thereby identifying missed populations and tailoring interventions to improve immunization equity and completeness .
Booster doses in the UIP are essential for maintaining long-lasting immunity against infectious diseases that can wane over time after the initial vaccination series. They are crucial for reinforcing immunity in children aged 1–5 years, thereby providing continued protection against potentially life-threatening infections. By ensuring sustained immunity, booster doses help prevent disease resurgence and contribute to the overall goal of reducing morbidity and vaccine-preventable mortality rates .
The inclusion of new vaccines into the UIP demonstrates India's adaptability and responsiveness to changing public health demands by addressing emerging health threats and disease burdens. For instance, the addition of the Hib-containing Pentavalent vaccine reflects an intent to combat bacterial diseases like pneumonia and meningitis, thereby responding to identified public health gaps. This ongoing evolution showcases India's commitment to aligning with global health standards, improving vaccine accessibility, and optimizing disease prevention strategies .
The Hib-containing Pentavalent vaccine under UIP combines vaccines for DPT (Diphtheria, Pertussis, and Tetanus Toxoid), Hepatitis B, and Haemophilus influenzae type B (Hib). This combination not only simplifies the vaccination process but also addresses multiple diseases with a single shot, thereby increasing vaccination compliance and coverage. Hib is a significant cause of bacterial meningitis and pneumonia in children, so its inclusion in the UIP is critical for reducing disease prevalence and preventing associated morbidities and mortalities .
The strategic goals of India's Universal Immunisation Program (UIP) include lowering baby and child death rates through immunization against serious diseases, eradicating and controlling preventable diseases such as polio, tetanus, measles, and diphtheria, achieving universal vaccination coverage for all children and pregnant women, and increasing public immunity by raising vaccine acceptability and knowledge . These goals address public health priorities by targeting diseases that contribute significantly to morbidity and mortality rates, striving for complete immunization coverage to ensure no one is left behind, and promoting health equity by focusing on vulnerable populations .
The UIP contributes to achieving WHO's Immunization Agenda 2030 goals by focusing on equitable access to immunization services, reducing morbidity and mortality from vaccine-preventable diseases, and striving to reach underserved or missed populations through initiatives like Mission Indradhanush. Its emphasis on bolstering the cold chain infrastructure and AEFI monitoring aligns UIP with global strategies for maintaining vaccine safety and effectiveness, thereby supporting WHO's vision of leaving no one behind in immunization efforts .
Achieving universal vaccination coverage in India faces challenges like logistical issues in vaccine distribution, maintaining an effective cold chain, ensuring vaccine availability in remote areas, and addressing vaccine hesitancy due to socio-cultural factors . Strategies to overcome these challenges include the deployment of Mission Indradhanush, which targets children and pregnant women who missed vaccinations, the Intensified Mission Indradhanush focusing on hard-to-reach populations, employing Vaccine Logistics Management Systems (VLMS) for efficient tracking of vaccine inventories, and enhancing AEFI surveillance to build trust in vaccine safety .
The National Family Health Survey-5 indicates that increased immunization coverage in India has positively impacted public health outcomes by reducing the incidence of vaccine-preventable diseases. With over 76% of children fully immunized, there has been a resultant decrease in child morbidity and mortality rates. The broader coverage has contributed to improved herd immunity, indirectly protecting those who are unvaccinated, and has set the stage for significant long-term health benefits across communities .